Sang Hee Woo's research while affiliated with Korea Centers for Disease Control and Prevention and other places

Publications (3)

Article
Full-text available
A real-time reverse transcription polymerase chain reaction (RT-qPCR) assay that does not require Emergency Use Authorization (EUA) reagents was tested and validated for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early stages of the outbreak of coronavirus disease 2019 (COVID-19) in the Republic of Kore...
Preprint
Full-text available
Background: A real-time reverse transcription polymerase chain reaction (RT-PCR) assay for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was developed to rapidly diagnose coronavirus disease 2019 (COVID-19). Early diagnosis of COVID-19 enables timely treatment and the implementation of public health measures. We validated t...
Article
Full-text available
Objectives: Following reports of patients with unexplained pneumonia at the end of December 2019 in Wuhan, China, the causative agent was identified as coronavirus (SARS-CoV-2), and the 2019 novel coronavirus disease was named COVID-19 by the World Health Organization. Putative patients with COVID-19 have been identified in South Korea, and attemp...

Citations

... The samples are collected from parts of the body where the coronavirus collects, such as a person's nose or throat. These samples were inserted into the polymerase chain reaction (PCR) tool and used optimal primers and probes to extract RNA from the virus [7], [8]. Based on the extraction/sequencing results, the SARS-CoV-2 genome has a length of 29,891 bp with a frequency of G and C of 38% [9]. ...